---
title: 'Repeat surgery of recurrent glioma for molecularly informed treatment in the
  age of precision oncology: A risk-benefit analysis'
date: '2024-02-09'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38334907/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240209170550&v=2.18.0
source: heidelberg[Affiliation]
description: 'CONCLUSION: Surgery for recurrent glioma provides relevant molecular
  diagnostic information with a direct consequence for targeted therapy under a reasonable
  risk of postoperative complications. With satisfactory postoperative survival it
  can therefore complement a multi-modal glioma therapy ...'
disable_comments: true
---
CONCLUSION: Surgery for recurrent glioma provides relevant molecular diagnostic information with a direct consequence for targeted therapy under a reasonable risk of postoperative complications. With satisfactory postoperative survival it can therefore complement a multi-modal glioma therapy ...